Clinical Trials Browser

Stage III and IV Ovarian Cancer × Neoadjuvant Therapy × 1 year × Clear all

NCT06980545 2025-05-20

Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer

Phase 3 Not yet recruiting

Stage III and IV Ovarian Cancer